Responses
Rheumatoid arthritis
Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis
Compose a Response to This Article
Other responses
No responses have been published for this article.